SCIENTIFIC AFFAIRS GROUP
At Ellipses, we take a different approach. We are assembling an unprecedented global network of the world’s best oncologists to be part of our Scientific Affairs Group, chaired by Professor Gordon McVie.
We have developed a proprietary technology platform which enables us to harness these leading minds in oncology around the globe.
0 in 2
People will get cancer
0
Types of Cancer
0
Children diagnosed with cancer this year
PATIENT IMPACT
The prestigious members of our Scientific Affairs Group assist in the selection of the most promising drugs and the design of efficient, effective clinical trials.Our continual engagement with leading oncologists helps us gather early clinician buy-in for the development of drugs with the patient and end-user always in mind.
MAKING THE DIFFERENCE
MORE DISCOVERIES
MORE CLINICAL TRIALS
MORE LIVES SAVED
RELEASING THE BOTTLENECK
If you wish to know more about Ellipses Pharma and our approach to developing cancer treatment please contact our team.